Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 621 (LINC00621) is a human lncRNA gene found on chromosome 13q12.12[15]. It encodes a long non-coding RNA molecule variably expressed in normal and tumor tissues, notably upregulated in lung adenocarcinoma and associated with poor clinical outcomes[2]. LINC00621 acts mechanistically as a molecular sponge for miR-34a-5p, resulting in the upregulation of TGFBR1 and increased activation of the TGF-β signaling pathway, promoting tumorigenesis and metastasis[2]. Its expression is transcriptionally upregulated by FOXA1, a transcription factor involved in chromatin remodeling. LINC00621 is being actively investigated as a biomarker for cancer prognosis and as a potential therapeutic target[2][5][6][15].
As of current data, drugs would be expected to modulate LINC00621 expression or function, likely through antisense oligonucleotides, RNA interference, or small molecules influencing its transcriptional regulation or miRNA sponging activity[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 621 (LINC00621).